Background
Background Panic disorder can be Panic disorder can be treated with psychotherapy, pharmacotreated with psychotherapy, pharmacotherapy or a combination of both. therapy or a combination of both.
Aims Aims To summarise the evidence
To summarise the evidence concerning the short-and long-term concerning the short-and long-term benefits and adverse effects of a benefits and adverse effects of a combination of psychotherapy and combination of psychotherapy and antidepressanttreatment. antidepressanttreatment.
Method
Method Meta-analyses and metaMeta-analyses and metaregressions were undertaken using data regressions were undertaken using data from all relevant randomised controlled from all relevant randomised controlled trials identified by a comprehensive trials identified by a comprehensive literature search.The primary outcome literature search.The primary outcome was relative risk (RR) of response. was relative risk (RR) of response.
Results

Results We identified 23 randomised
We identified 23 randomised comparisons (21trials involving a total of comparisons (21trials involving a total of 1709 patients).In the acute-phase 1709 patients).In the acute-phase treatment, the combined therapy was treatment, the combined therapy was superior to antidepressant pharmacosuperior to antidepressant pharmacotherapy (RR therapy (RR¼1.24, 95% CI1.02^1.52) or 1.24, 95% CI1.02^1.52) or psychotherapy (RR psychotherapy (RR¼1.16, 95% CI1.031.16, 95% CI1.031 .30) . After termination ofthe acute-phase 1.30). After termination ofthe acute-phase treatment, the combined therapy was treatment, the combined therapy was more effective than pharmacotherapy more effective than pharmacotherapy alone (RR alone (RR¼1.61, 95% CI1.23^2.11) and was 1.61, 95% CI1.23^2.11) and was as effective as psychotherapy (RR as effective as psychotherapy (RR¼0.96, 0.96, 95% CI 0.79^1.16). 95% CI 0.79^1.16).
Conclusions Conclusions Either combined therapy
Either combined therapy or psychotherapy alone may be chosen as or psychotherapy alone may be chosen as first-line treatment for panic disorder with first-line treatment for panic disorder with or without agoraphobia, depending onthe or without agoraphobia, depending onthe patient's preferences. patient's preferences.
Declaration of interest Declaration of interest T.A.F. has
T.A.F. has received research grants and fees for received research grants and fees for speaking from several pharmaceutical speaking from several pharmaceutical companies.These companies did not companies.These companies did not provide funding for the current study (see provide funding for the current study (see Acknowledgements). Acknowledgements).
Two categories of treatment have been Two categories of treatment have been shown to be effective in treating panic shown to be effective in treating panic disorder with or without agoraphobia. disorder with or without agoraphobia. One is psychotherapy and the other is One is psychotherapy and the other is pharmacotherapy using antidepressants pharmacotherapy using antidepressants and benzodiazepines (American Psychiatric and benzodiazepines (American Psychiatric Association, 1998; Nathan & Gorman, Association, 1998; Nathan & Gorman, 2002) . However, it is uncertain whether 2002). However, it is uncertain whether combining these two forms of treatment combining these two forms of treatment confers any additional benefit over and confers any additional benefit over and above either treatment alone, both in the above either treatment alone, both in the short term and in the long term. The short term and in the long term. The primary objective of this systematic review primary objective of this systematic review was therefore to review and synthesise was therefore to review and synthesise evidence from randomised controlled trials evidence from randomised controlled trials that examined the short-and long-term that examined the short-and long-term benefits and adverse effects of a combenefits and adverse effects of a combination of psychotherapy and antibination of psychotherapy and antidepressants compared with either therapy depressants compared with either therapy alone for the treatment of panic disorder. alone for the treatment of panic disorder. A separate review that focuses on the use A separate review that focuses on the use of psychotherapy in combination with of psychotherapy in combination with benzodiazepines is in preparation. benzodiazepines is in preparation.
METHOD METHOD
Inclusion criteria Inclusion criteria
Randomised controlled trials that comRandomised controlled trials that compared a combination of psychotherapy pared a combination of psychotherapy and antidepressant pharmacotherapy with and antidepressant pharmacotherapy with either treatment alone for adult patients either treatment alone for adult patients with panic disorder, with or without with panic disorder, with or without agoraphobia, were eligible for inclusion. agoraphobia, were eligible for inclusion.
We included both individual and group We included both individual and group formats of behaviour therapy involving formats of behaviour therapy involving some kind of exposure, cognitive therapy some kind of exposure, cognitive therapy involving some kind of cognitive restructurinvolving some kind of cognitive restructuring, cognitive-behavioural therapy involing, cognitive-behavioural therapy involving elements of both cognitive and ving elements of both cognitive and behavioural therapy, and other psychologibehavioural therapy, and other psychological approaches. All commonly prescribed cal approaches. All commonly prescribed antidepressants were eligible, including triantidepressants were eligible, including tricyclic antidepressants (TCAs) and selective cyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs). serotonin reuptake inhibitors (SSRIs).
Studies in which there was irregular use Studies in which there was irregular use of benzodiazepines or in which benzodiazeof benzodiazepines or in which benzodiazepines were regularly administered at a pines were regularly administered at a constant dosage for long-term users were constant dosage for long-term users were included, because it was considered that included, because it was considered that these did not undermine the comparability these did not undermine the comparability of the combined therapy with either monoof the combined therapy with either monotherapy, and because such practices would therapy, and because such practices would reflect clinical reality more closely. The reflect clinical reality more closely. The effect of this decision was examined in a effect of this decision was examined in a sensitivity analysis. Studies in which benzosensitivity analysis. Studies in which benzodiazepines were combined with antidepresdiazepines were combined with antidepressants as part of the study medication were sants as part of the study medication were excluded. excluded. Two reviewers examined the titles and Two reviewers examined the titles and abstracts of studies identified by the elecabstracts of studies identified by the electronic search, and then checked the full artronic search, and then checked the full articles for eligibility. To identify further ticles for eligibility. To identify further trials, the references cited in these studies trials, the references cited in these studies and in other review papers were also and in other review papers were also checked, relevant studies were subjected checked, relevant studies were subjected to SciSearch, and experts in the field were to SciSearch, and experts in the field were contacted. contacted.
Identification of trials Identification of trials
Quality assessment and data Quality assessment and data extraction extraction
Two independent reviewers assessed the Two independent reviewers assessed the methodological quality of the selected stumethodological quality of the selected studies according to the recommendations of dies according to the recommendations of the the Cochrane Reviewers' Handbook 4.2.2
Cochrane Reviewers' Handbook 4.2.2 (Alderson , which emphasises , 2004), which emphasises allocation concealment (A, low risk of bias; allocation concealment (A, low risk of bias; B, moderate risk of bias; C, high risk of B, moderate risk of bias; C, high risk of bias). We also rated the study as 'blinded' bias). We also rated the study as 'blinded' when at least one outcome measure was when at least one outcome measure was assessed by an independent assessor who assessed by an independent assessor who was masked to treatment allocation, and was masked to treatment allocation, and 'unblinded' when the outcomes were 'unblinded' when the outcomes were assessed by someone who was aware of assessed by someone who was aware of the allocated treatment. the allocated treatment.
3 0 5 3 0 5 In addition, we rated the adequacy of In addition, we rated the adequacy of the psychotherapy as 'good' when the way the psychotherapy as 'good' when the way in which psychotherapy was actually conin which psychotherapy was actually conducted was examined by a third reviewer ducted was examined by a third reviewer by means of audiotapes, etc., and as 'poor' by means of audiotapes, etc., and as 'poor' when the authors only provided a when the authors only provided a description of the therapy procedure. description of the therapy procedure.
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
Two reviewers independently extracted Two reviewers independently extracted data from the original reports using standdata from the original reports using standardised data-extraction forms. Our primary ardised data-extraction forms. Our primary outcome was 'response' -that is, substanoutcome was 'response' -that is, substantial improvement from baseline, such as tial improvement from baseline, such as 'very much or much improved' according 'very much or much improved' according to the Clinical Global Impression scale to the Clinical Global Impression scale (CGI; Guy, 1976), a decrease of more than (CGI; Guy, 1976), a decrease of more than 40% in the Panic Disorder Severity Scale 40% in the Panic Disorder Severity Scale score (Shear score (Shear et al et al, 1997) , and a reduction , 1997), and a reduction of more than 50% in panic frequency or of more than 50% in panic frequency or the Fear Questionnaire -Agoraphobia the Fear Questionnaire -Agoraphobia sub-scale (Marks & Mathews, 1979) . Our sub-scale (Marks & Mathews, 1979) . Our secondary outcomes included global seversecondary outcomes included global severity, frequency of panic attacks, phobic ity, frequency of panic attacks, phobic avoidance, general anxiety, depression, soavoidance, general anxiety, depression, social dysfunction, patient satisfaction and cial dysfunction, patient satisfaction and cost-effectiveness. The total number of cost-effectiveness. The total number of drop-outs for any reason was regarded as drop-outs for any reason was regarded as a proxy measure of the acceptability of a proxy measure of the acceptability of treatment. Adverse effects were evaluated treatment. Adverse effects were evaluated by examining the number of drop-outs by examining the number of drop-outs due to adverse effects. due to adverse effects.
Any discrepancies were resolved by Any discrepancies were resolved by consensus between two or, where necesconsensus between two or, where necessary, between all three reviewers. The decisary, between all three reviewers. The decision to include in the meta-analysis studies sion to include in the meta-analysis studies that did not appropriately conceal allocathat did not appropriately conceal allocation, that were 'unblinded' or that scored tion, that were 'unblinded' or that scored 'poor' with regard to adequacy of psy-'poor' with regard to adequacy of psychotherapy was examined in sensitivity chotherapy was examined in sensitivity analyses. analyses.
Data synthesis Data synthesis
Data were entered into Review Manager Data were entered into Review Manager 4.2 (Windows software provided by the 4.2 (Windows software provided by the Cochrane Collaboration and available at Cochrane Collaboration and available at http://www.cc-ims.net/RevMan) and doublehttp://www.cc-ims.net/RevMan) and doublechecked for accuracy. For dichotomous checked for accuracy. For dichotomous outcomes, relative risk (RR) and 95% conoutcomes, relative risk (RR) and 95% confidence intervals were calculated using a fidence intervals were calculated using a random-effects model, which yields superrandom-effects model, which yields superior results in terms of clinical interpretabilior results in terms of clinical interpretability and external generalisability compared ity and external generalisability compared with fixed-effects models and odds ratios with fixed-effects models and odds ratios or risk differences (Furukawa or risk differences (Furukawa et al et al, 2002) . , 2002). For continuous outcomes, the standardised For continuous outcomes, the standardised weighted mean difference (SMD) and 95% weighted mean difference (SMD) and 95% confidence intervals were calculated using a confidence intervals were calculated using a random-effects model. random-effects model.
For dichotomous outcomes, we used For dichotomous outcomes, we used intention-to-treat analyses according to intention-to-treat analyses according to the following principle. When data on the following principle. When data on drop-outs were carried forward and drop-outs were carried forward and included in the efficacy evaluation using included in the efficacy evaluation using the last-observation-carried-forward meththe last-observation-carried-forward method, they were included as such. When od, they were included as such. When drop-outs were excluded from any assessdrop-outs were excluded from any assessment in the primary studies (e.g. those ment in the primary studies (e.g. those who never returned for assessment after who never returned for assessment after randomisation), they were considered to randomisation), they were considered to be non-responders in both active and combe non-responders in both active and comparison groups. The same principles were parison groups. The same principles were applied to outcomes after the end of applied to outcomes after the end of continuation treatment. continuation treatment. In addition, sensitivity analyses were In addition, sensitivity analyses were performed, restricting the data syntheses performed, restricting the data syntheses to studies of higher quality in terms of alloto studies of higher quality in terms of allocation concealment, blinding, operational cation concealment, blinding, operational diagnosis, adequacy of psychotherapy and diagnosis, adequacy of psychotherapy and control of benzodiazepine co-intervention. control of benzodiazepine co-intervention. Meta-regressions (Thompson & Sharp, Meta-regressions (Thompson & Sharp, 1999) were also performed to determine 1999) were also performed to determine whether these variables had a significant whether these variables had a significant effect on the pooled effect sizes. effect on the pooled effect sizes.
Subgroup and sensitivity analyses Subgroup and sensitivity analyses
RESULTS RESULTS
Description of studies Description of studies
The electronic search identified 139 studies The electronic search identified 139 studies from CCDANCTR, an additional 164 stufrom CCDANCTR, an additional 164 studies from CENTRAL and 35 studies from dies from CENTRAL and 35 studies from Medline. By browsing their titles and abMedline. By browsing their titles and abstracts, the two independent reviewers idenstracts, the two independent reviewers identified 135 articles as possible candidates, tified 135 articles as possible candidates, and full copies of these articles were oband full copies of these articles were obtained. Two independent reviewers then extained. Two independent reviewers then examined the strict eligibility of these papers. amined the strict eligibility of these papers. As a result of a further reference search, SciAs a result of a further reference search, SciSearch and personal contacts, we identified Search and personal contacts, we identified 21 studies which satisfied the strict eligibil-21 studies which satisfied the strict eligibility criteria. The interrater reliability of the ity criteria. The interrater reliability of the eligibility criteria was found to be 94%. Beeligibility criteria was found to be 94%. Because two trials provided two comparisons cause two trials provided two comparisons each (Sheehan each (Sheehan et al et al, 1980; Mavissakalian , 1980; Mavissakalian & Michelson, 1986) Table 1 is presented as a data supplement to the online version of data supplement to the online version of this paper). this paper).
The majority of the participants were The majority of the participants were women, and their average age was between women, and their average age was between 30 and 40 years. They had suffered from 30 and 40 years. They had suffered from panic disorder for 5 to 10 years. Only one panic disorder for 5 to 10 years. Only one comparison focused on patients with panic comparison focused on patients with panic disorder without agoraphobia, whereas 13 disorder without agoraphobia, whereas 13 comparisons focused on patients with panic comparisons focused on patients with panic disorder with agoraphobia. The other disorder with agoraphobia. The other studies were of mixed populations. studies were of mixed populations.
The typical length of the acute-phase The typical length of the acute-phase active treatment was between 8 and 12 active treatment was between 8 and 12 weeks. In total, 12 studies administered beweeks. In total, 12 studies administered behaviour therapy that consisted of exposure haviour therapy that consisted of exposure and/or breathing retraining and/or relaxaand/or breathing retraining and/or relaxation exercises. None of the studies used nartion exercises. None of the studies used narrowly defined cognitive therapy that relied rowly defined cognitive therapy that relied only on cognitive restructuring. Nine only on cognitive restructuring. Nine studies administered cognitive-behavioural studies administered cognitive-behavioural therapy that consisted of both behaviour therapy that consisted of both behaviour and cognitive therapy elements. Two and cognitive therapy elements. Two studies were categorised as 'Other psystudies were categorised as 'Other psychotherapies'. One of these used a mixture chotherapies'. One of these used a mixture of cognitive-behavioural therapy and interof cognitive-behavioural therapy and interpersonal psychotherapy (Berger personal psychotherapy (Berger et al et al, 2004) , 2004) and the other used brief psychodynamic and the other used brief psychodynamic psychotherapy (Wiborg & Dahl, 1996) . psychotherapy (Wiborg & Dahl, 1996) . With regard to medications that were admiWith regard to medications that were administered, 14 studies used TCAs (with an nistered, 14 studies used TCAs (with an average dose of 146 mg/day of imipramine average dose of 146 mg/day of imipramine equivalents), 7 studies used SSRIs (average equivalents), 7 studies used SSRIs (average dose 32 mg/day fluoxetine equivalents) dose 32 mg/day fluoxetine equivalents) and 2 studies used monoamine oxidase and 2 studies used monoamine oxidase inhibitors. inhibitors.
Response was defined in terms of the Response was defined in terms of the CGI scale in eight studies, in terms of the CGI scale in eight studies, in terms of the Fear Questionnaire Agoraphobia sub-scale Fear Questionnaire Agoraphobia sub-scale in three studies, in terms of panic frequency in three studies, in terms of panic frequency in two studies, and in terms of other in two studies, and in terms of other measures in 10 studies. In total, 13 studies measures in 10 studies. In total, 13 studies reported continuous outcomes of global reported continuous outcomes of global severity, 15 reported on panic frequency, severity, 15 reported on panic frequency, 20 reported on agoraphobia, 18 reported 20 reported on agoraphobia, 18 reported on general anxiety, 18 reported on depreson general anxiety, 18 reported on depression and 13 reported on social dysfunction. sion and 13 reported on social dysfunction. None of the studies reported on patient None of the studies reported on patient satisfaction or cost issues. satisfaction or cost issues.
Six studies reported the results at the Six studies reported the results at the end of continuation treatment which lasted end of continuation treatment which lasted for between 3 and 9 months. Nine studies for between 3 and 9 months. Nine studies followed up the patients 6-24 months followed up the patients 6-24 months after termination of acute-phase and after termination of acute-phase and continuation treatments. continuation treatments.
With regard to validity, all but four With regard to validity, all but four comparisons from three trials (Mavissakacomparisons from three trials (Mavissakalian & Michelson, 1986; Wiborg & Dahl, lian & Michelson, 1986; Wiborg & Dahl, 1996; Berger 1996; Berger et al et al, 2004 ) scored B for allo-, 2004) scored B for allocation concealment. In total, 19 studies cation concealment. In total, 19 studies conducted blinded outcome assessments conducted blinded outcome assessments 3 0 6 3 0 6 and four studies were unblinded (Mavissaand four studies were unblinded (Mavissakalian kalian et al et al, 1983; Spinhoven , 1983; Spinhoven et al et al, 1996; , 1996; Azhar, 2000; Berger Azhar, 2000; Berger et al et al, 2004) . The inter-, 2004). The interrater reliability of these two validity criteria rater reliability of these two validity criteria was 94% for allocation concealment and was 94% for allocation concealment and 83% for outcome assessment. 83% for outcome assessment.
Six studies reported that quality control Six studies reported that quality control of the psychotherapy was adequate (Zitrin of the psychotherapy was adequate (Zitrin et al et al, 1983; de Beurs , 1983; de Beurs et al et al, 1995; Fava , 1995; Fava et al et al, 1997; Loerch , 1997; Loerch et al et al, 1999; Barlow , 1999; Barlow et et al al, 2000; Kampman , 2000; Kampman et al et al, 2002) . Four , 2002) . Four studies acknowledged financial support studies acknowledged financial support from pharmaceutical companies (Fahy from pharmaceutical companies (Fahy et et al al, 1992; de Beurs , 1992; de Beurs et al et al, 1995; Sharp , 1995; Sharp et al et al, , 1996; Loerch 1996; Loerch et al et al, 1999) , and these , 1999), and these companies marketed the drugs involved in companies marketed the drugs involved in the trials. Oehrberg the trials. Oehrberg et al et al (1995) did not (1995) did not acknowledge financial support from a drug acknowledge financial support from a drug company, but three of the co-authors of company, but three of the co-authors of that study were company employees. that study were company employees.
Psychotherapy plus antidepressant Psychotherapy plus antidepressant v. v. antidepressant treatment antidepressant treatment
Acute-phase treatment Acute-phase treatment
Combining data from 11 studies involving Combining data from 11 studies involving 322 patients in the psychotherapy plus anti-322 patients in the psychotherapy plus antidepressant arm and 347 patients in the depressant arm and 347 patients in the antidepressant arm showed that the antidepressant arm showed that the combination was 1.24 times (95% CI combination was 1.24 times (95% CI 1.02-1.52) more likely to produce a response 1.02-1.52) more likely to produce a response at the end of 2-4 months of acute-phase at the end of 2-4 months of acute-phase treatment compared with the antidepressant treatment compared with the antidepressant alone ( Fig. 1) . There was moderate but alone ( Fig. 1) . There was moderate but statistically significant heterogeneity ( statistically significant heterogeneity (P P¼ 0.05, 0.05, I I 2 2 ¼44.9%). Furthermore, the funnel 44.9%). Furthermore, the funnel plot indicated that there was some publicaplot indicated that there was some publication bias, with one small study reporting an tion bias, with one small study reporting an extreme result (Telch extreme result (Telch et al et al, 1985) . Sub-, 1985) . Subgroup analyses suggested that there was group analyses suggested that there was greater heterogeneity in the 'other psychogreater heterogeneity in the 'other psychotherapies' category (Wiborg & Dahl, therapies' category (Wiborg & Dahl, 1996; Berger 1996; Berger et al et al, 2004 ). When we omitted , 2004). When we omitted these studies, limiting the included studies these studies, limiting the included studies to those that employed behavioural or to those that employed behavioural or cognitive-behavioural therapies, the RR cognitive-behavioural therapies, the RR remained the same (RR remained the same (RR¼1.28, 95% CI 1.28, 95% CI 1.08-1.52) and there was no longer statisti-1.08-1.52) and there was no longer statistical heterogeneity ( cal heterogeneity (P P¼0.18, 0.18, I I 2 2 ¼30.5%) or 30.5%) or funnel-plot asymmetry. funnel-plot asymmetry.
The superiority of the combination The superiority of the combination therapy was corroborated by secondary therapy was corroborated by secondary analyses using continuous data. The combianalyses using continuous data. ). There were no differences in overall There were no differences in overall drop-outs or in drop-outs due to side-effects. drop-outs or in drop-outs due to side-effects.
Continuation treatment Continuation treatment
There was considerable statistical heteroThere was considerable statistical heterogeneity ( geneity (P P¼0.005, 0.005, I I After termination of treatment After termination of treatment Figure 2 shows the findings of five studies Figure 2 shows the findings of five studies that reported outcomes after 6-24 months that reported outcomes after 6-24 months of naturalistic follow-up. Combining outof naturalistic follow-up. Combining outcomes based on 376 participants, the comcomes based on 376 participants, the combination therapy was still superior to bination therapy was still superior to antidepressant treatment alone (RR antidepressant treatment alone (RR¼1. (Fig. 3) . The ment than psychotherapy alone (Fig. 3) . The test for heterogeneity was not significant. test for heterogeneity was not significant. The same superiority of the combined The same superiority of the combined therapy was noted with regard to the global therapy was noted with regard to the global severity (SMD severity (SMD¼7 70.43, 95% CI 0.43, 95% CI 7 70.60 to 0.60 to 7 70.26). When different aspects of panic 0.26). When different aspects of panic disorder were examined, the combination disorder were examined, the combination therapy was found to be significantly supertherapy was found to be significantly superior with regard to reduction in phobic ior with regard to reduction in phobic avoidance (SMD avoidance (SMD¼7 70.31 70.11). 0.11). Although the two arms did not differ in Although the two arms did not differ in terms of overall drop-out rates, drop-outs terms of overall drop-out rates, drop-outs due to side-effects were much more due to side-effects were much more 3 0 8 3 0 8 AUTHOR'S PROOF AUTHOR'S PROOF frequent in the combined therapy arm frequent in the combined therapy arm (RR (RR¼3.01, 95% CI 1.61-5.63). 3.01, 95% CI 1.61-5.63).
For as long as the treatments were conFor as long as the treatments were continued, the advantage of the combination tinued, the advantage of the combination therapy appeared to persist, as the response therapy appeared to persist, as the response rate at the end of continuation treatment rate at the end of continuation treatment still favoured the combination therapy still favoured the combination therapy (RR (RR¼1.23, 95% CI 1.00-1.51), and the 1.23, 95% CI 1.00-1.51), and the global severity was significantly lower in global severity was significantly lower in the combination arm (SMD the combination arm (SMD¼7 70.65, 95% 0.65, 95% CI CI 7 70.97 to 0.97 to 7 70.33). 0.33).
After termination of treatment After termination of treatment
In total, 658 patients from nine studies In total, 658 patients from nine studies were assessed 6 to 24 months after disconwere assessed 6 to 24 months after discontinuing treatment (Fig. 4) . Neither the tinuing treatment (Fig. 4) . Neither the response rate nor the global severity response rate nor the global severity measure differed significantly between the measure differed significantly between the two arms, which suggests that any two arms, which suggests that any advantage of the combination therapy advantage of the combination therapy disappeared over time. disappeared over time.
Subgroup and sensitivity analyses Subgroup and sensitivity analyses
Types of psychotherapy Types of psychotherapy
For all the outcomes during the acute-phase For all the outcomes during the acute-phase or continuation treatments or after termior continuation treatments or after termination of treatment, the confidence nation of treatment, the confidence intervals of the pooled estimates of the intervals of the pooled estimates of the effectiveness of behaviour therapy and effectiveness of behaviour therapy and cognitive-behavioural therapy overlapped cognitive-behavioural therapy overlapped to a significant degree (Figs 1-4 ). Pooling to a significant degree (Figs 1-4 ). Pooling these two types of psychotherapy together these two types of psychotherapy together seldom resulted in significant heterogeneity. seldom resulted in significant heterogeneity. The only exception was the 'other psychoThe only exception was the 'other psychotherapies' category for the comparison of therapies' category for the comparison of psychotherapy plus antidepressant with psychotherapy plus antidepressant with antidepressant treatment alone. The results antidepressant treatment alone. The results of these studies were sometimes direcof these studies were sometimes directionally different from those of the other tionally different from those of the other studies in which behavioural or cognitivestudies in which behavioural or cognitivebehavioural therapies were administered, behavioural therapies were administered, and combining them often resulted in and combining them often resulted in significant heterogeneity. significant heterogeneity.
Classes of antidepressants Classes of antidepressants
We performed a meta-analysis of 14 studies We performed a meta-analysis of 14 studies in which TCAs were used and 7 studies in in which TCAs were used and 7 studies in which SSRIs were used. The pooled which SSRIs were used. The pooled estimates of the effect size of these two estimates of the effect size of these two meta-analyses were very similar both to meta-analyses were very similar both to each other and to the overall results in each other and to the overall results in terms of response or global severity terms of response or global severity (Table 2) . (Table 2) .
Patients with and without agoraphobia Patients with and without agoraphobia
We performed a meta-analysis of 13 studies We performed a meta-analysis of 13 studies that focused on patients with agoraphobia that focused on patients with agoraphobia only. The results were very similar to the only. The results were very similar to the overall results, and overlapped substanoverall results, and overlapped substantially with the results of the only study that tially with the results of the only study that focused on patients without agoraphobia focused on patients without agoraphobia (Barlow (Barlow et al et al, 2000) ( Table 2) . , 2000) ( Table 2) . When only those studies that were of When only those studies that were of higher quality in terms of allocation conhigher quality in terms of allocation concealment, blinding, diagnostic accuracy, cealment, blinding, diagnostic accuracy, adequacy of psychotherapy or control of adequacy of psychotherapy or control of benzodiazepine co-intervention were inbenzodiazepine co-intervention were included, the pooled estimates that were cluded, the pooled estimates that were obtained were virtually identical to the obtained were virtually identical to the overall results. Meta-regression analysis overall results. Meta-regression analysis 3 0 9 3 0 9 AUTHOR'S PROOF AUTHOR'S PROOF PT, psychotherapy; AD, antidepressant; RR, relative risk. 1. Comparison A of two from this study; 2. compari-PT, psychotherapy; AD, antidepressant; RR, relative risk. 1. Comparison A of two from this study; 2. comparison B of two from this study. son B of two from this study.
did not reveal any significant contribution did not reveal any significant contribution of these quality variables, either individuof these quality variables, either individually or in combination, which suggests that ally or in combination, which suggests that the overall findings are robust. the overall findings are robust.
DISCUSSION DISCUSSION
Importance of the clinical problem Importance of the clinical problem in the context of previous reviews in the context of previous reviews
There are a number of reasons why the clinThere are a number of reasons why the clinical question concerning combined psychoical question concerning combined psychotherapy and antidepressant treatment is therapy and antidepressant treatment is important. First, combination therapy is important. First, combination therapy is frequently provided in clinical practice, frequently provided in clinical practice, possibly because 30-50% of patients possibly because 30-50% of patients remain unimproved at the end of acuteremain unimproved at the end of acutephase treatment by either monotherapy. phase treatment by either monotherapy. Second, it is now increasingly recognised Second, it is now increasingly recognised that pharmacotherapy alone tends to result that pharmacotherapy alone tends to result in substantial relapse rates not only when in substantial relapse rates not only when discontinued (Mavissakalian & Perel, discontinued (Mavissakalian & Perel, 2002) , but even when maintained at 2002), but even when maintained at adequate dosage (Simon adequate dosage (Simon et al et al, 2002 (Simon et al et al, ), , 2002 ), whereas psychotherapy is associated with whereas psychotherapy is associated with fewer relapses in the short term, but may fewer relapses in the short term, but may not always be able to prevent them in the not always be able to prevent them in the long term (Fava long term (Fava et al et al, 2001) . , 2001). Several reviews of combination therapy Several reviews of combination therapy can be found in the literature, but their concan be found in the literature, but their conclusions have been variable, with some clusions have been variable, with some favouring the combination (Mattick favouring the combination (Mattick et al et al, , 1990; van Balkom 1990; van Balkom et al et al, 1997) , some , 1997), some favouring monotherapy (Gould favouring monotherapy (Gould et al et al, , 1995; Taylor, 2000) and others drawing 1995; Taylor, 2000) and others drawing mixed or cautious conclusions (American mixed or cautious conclusions (American Psychiatric Association, 1998; Schmidt Psychiatric Association, 1998; Schmidt et et al al, 2001 ). Most of these reviews have been , 2001). Most of these reviews have been either unsystematic or narrative only either unsystematic or narrative only (American Psychiatric Association, 1998; (American Psychiatric Association, 1998; Taylor, 2000; Schmidt Taylor, 2000; Schmidt et al et al, 2001 Schmidt et al et al, ) and, , 2001 ) and, where meta-analytical summary was where meta-analytical summary was undertaken, this did not focus on head-toundertaken, this did not focus on head-tohead comparisons (Mattick head comparisons (Mattick et al et al, 1990; , 1990; Gould Gould et al et al, 1995; van Balkom , 1995; van Balkom et al et al, , 1997) , a practice that is known to be 1997), a practice that is known to be misleading (Song misleading (Song et al et al, 2003) . , 2003).
Current findings Current findings
This systematic review demonstrated that This systematic review demonstrated that combining psychotherapy and antidepressant combining psychotherapy and antidepressant treatment produced outcomes that were treatment produced outcomes that were consistently superior to either treatment consistently superior to either treatment alone for the acute-phase treatment, in alone for the acute-phase treatment, in terms of both the response rates and the terms of both the response rates and the continuous outcomes measuring various ascontinuous outcomes measuring various aspects of the disorder. Taking the average repects of the disorder. Taking the average response rates of 50-70% for single-modality sponse rates of 50-70% for single-modality treatments, the pooled RR of 1.2 for the treatments, the pooled RR of 1.2 for the combination therapy is equivalent to a combination therapy is equivalent to a value for the number needed to treat of bevalue for the number needed to treat of between 7 and 10. During the acute-phase tween 7 and 10. During the acute-phase treatment, combination therapy resulted in treatment, combination therapy resulted in more drop-outs due to side-effects than psymore drop-outs due to side-effects than psychotherapy alone, and the number needed chotherapy alone, and the number needed to harm was around 26. to harm was around 26. The naturalistic follow-up of the ranThe naturalistic follow-up of the randomised controlled trials that were indomised controlled trials that were included suggested that the combination cluded suggested that the combination therapy had a sustained advantage over therapy had a sustained advantage over antidepressant therapy. At 6-24 months antidepressant therapy. At 6-24 months after termination of treatment, the comafter termination of treatment, the combined therapy still showed a number needed bined therapy still showed a number needed to treat of around 6 compared with antito treat of around 6 compared with antidepressant treatment alone. With regard to depressant treatment alone. With regard to the comparison between the combination the comparison between the combination 31 0 31 0 AUTHOR'S PROOF AUTHOR'S PROOF therapy and psychotherapy, there was no therapy and psychotherapy, there was no evidence of long-term benefit of the former evidence of long-term benefit of the former compared with the latter. In this respect, it compared with the latter. In this respect, it is interesting to note that, despite recent adis interesting to note that, despite recent admonitions from several experts (Taylor, monitions from several experts (Taylor, 2000; Schmidt 2000; Schmidt et al et al, 2001; Foa , 2001; Foa et al et al, , 2002) , the combination therapy was found 2002), the combination therapy was found to have no disadvantage in the long term. to have no disadvantage in the long term.
Strengths and limitations Strengths and limitations
This systematic review has several major This systematic review has several major strengths. First, we performed systematic strengths. First, we performed systematic and comprehensive searches for relevant and comprehensive searches for relevant trials. We identified 23 randomised comtrials. We identified 23 randomised comparisons from 21 studies, whereas previous parisons from 21 studies, whereas previous reviews included a maximum of 13 studies. reviews included a maximum of 13 studies. Second, we applied the intention-to-treat Second, we applied the intention-to-treat principle when performing meta-analysis principle when performing meta-analysis of dichotomous outcomes by counting all of dichotomous outcomes by counting all of the drop-outs as non-responders. This of the drop-outs as non-responders. This policy is especially pertinent in the context policy is especially pertinent in the context of the relative merits of the combination of the relative merits of the combination therapy over monotherapy in the long term, therapy over monotherapy in the long term, because we are interested in the number of because we are interested in the number of patients doing well as a proportion of all patients doing well as a proportion of all those who started the acute-phase therapy, those who started the acute-phase therapy, not just those who successfully completed not just those who successfully completed it. Finally, the it. Finally, the a priori a priori planned heterogeneity planned heterogeneity and sensitivity analyses indicated that the and sensitivity analyses indicated that the results of the analyses were quite robust. results of the analyses were quite robust.
However, several potential limitations However, several potential limitations of this study must be acknowledged. First, of this study must be acknowledged. First, the comparability of the treatment arms the comparability of the treatment arms after termination of acute-phase and contiafter termination of acute-phase and continuation treatments may be compromised nuation treatments may be compromised by the naturalistic nature of the follow-up. by the naturalistic nature of the follow-up. Participants were usually free to seek Participants were usually free to seek further treatment between the termination further treatment between the termination of treatment and the follow-up assessments, of treatment and the follow-up assessments, and 30-77% of them received additional and 30-77% of them received additional therapies. Unfortunately, inadequate retherapies. Unfortunately, inadequate reporting of additional therapies precluded porting of additional therapies precluded further examination of this issue across further examination of this issue across studies. If the published studies had restudies. If the published studies had reported the number of patients who did well ported the number of patients who did well without further treatment, the interpretwithout further treatment, the interpretation of the relative merits of the combinaation of the relative merits of the combination therapy tion therapy v.
v. monotherapies would have monotherapies would have been more straightforward. Second, been more straightforward. Second, funnel-plot analyses suggested the possibilfunnel-plot analyses suggested the possibility of publication bias. However, the excluity of publication bias. However, the exclusion of outliers did not affect the pooled sion of outliers did not affect the pooled estimates. Third, we must point out that estimates. Third, we must point out that until recently there have been no widely until recently there have been no widely accepted and validated rating scales for accepted and validated rating scales for panic disorder, and that some of the studies panic disorder, and that some of the studies that were included used the authors' origithat were included used the authors' original scales. One study indicated that rating nal scales. One study indicated that rating scales which have not been validated or scales which have not been validated or standardised are more likely to report standardised are more likely to report statistically significant findings (Marshall statistically significant findings (Marshall et al et al, 2000) . Fourth, owing to this lack of , 2000). Fourth, owing to this lack of accepted assessment methods for panic accepted assessment methods for panic disorder, the definition of response (our pridisorder, the definition of response (our primary outcome) had to be operationalised mary outcome) had to be operationalised by a variety of measures. However, these by a variety of measures. However, these overall results were corroborated by anaoverall results were corroborated by analyses that focused on specific aspects of lyses that focused on specific aspects of the symptoms of panic disorder. the symptoms of panic disorder.
It must be noted that our review does It must be noted that our review does not address the relative merits of combinanot address the relative merits of combination therapy compared with sequential tion therapy compared with sequential treatments. Given the present findings, treatments. Given the present findings, some might argue for psychotherapy alone some might argue for psychotherapy alone as first-line treatment, only considering as first-line treatment, only considering combination therapy if psychotherapy fails. combination therapy if psychotherapy fails. Although this appears to be a viable option, Although this appears to be a viable option, such a practice cannot be informed by the such a practice cannot be informed by the data available from these trials. data available from these trials.
Clinical implications and future Clinical implications and future research research
The current findings from the best available The current findings from the best available evidence suggest that either combined therevidence suggest that either combined therapy or psychotherapy alone may be chosen apy or psychotherapy alone may be chosen as first-line treatment for panic disorder as first-line treatment for panic disorder with or without agoraphobia. Treatment with or without agoraphobia. Treatment decisions may depend on the patient's decisions may depend on the patient's preferences and values. Antidepressant preferences and values. Antidepressant pharmacotherapy alone is not to be pharmacotherapy alone is not to be recommended as first-line treatment where recommended as first-line treatment where appropriate resources are available. appropriate resources are available. Although none of the studies included in Although none of the studies included in this review examined cost issues, economic this review examined cost issues, economic consideration of the costs of years of mediconsideration of the costs of years of medication compared with 'one-off' psychologication compared with 'one-off' psychological treatment would also favour the use of cal treatment would also favour the use of psychotherapy (Otto psychotherapy (Otto et al et al, 2000) . , 2000). Several issues warrant further investigaSeveral issues warrant further investigation. First, in the acute-phase treatment, if tion. First, in the acute-phase treatment, if we adhere to the strict intention-to-treat we adhere to the strict intention-to-treat principle, the response rates are only principle, the response rates are only slightly above 50% for combination therapy slightly above 50% for combination therapy and slightly below 50% for psychotherapy and slightly below 50% for psychotherapy alone. Therefore additional strategies may alone. Therefore additional strategies may be required to deal with partial and nonbe required to deal with partial and nonresponders to these therapies. Second, there responders to these therapies. Second, there are currently only limited data available on are currently only limited data available on the effects of combining antidepressants the effects of combining antidepressants with non-cognitive-behavioural therapies, with non-cognitive-behavioural therapies, such as psychodynamic and interpersonal such as psychodynamic and interpersonal therapies. In this review, the only available therapies. In this review, the only available trial that involved psychodynamic therapy trial that involved psychodynamic therapy showed increased benefit when combined showed increased benefit when combined with antidepressants. This suggests the with antidepressants. This suggests the potential value of future trials designed to potential value of future trials designed to investigate this type of combination in the investigate this type of combination in the treatment of panic disorder. treatment of panic disorder. Oehrberg, S., Christiansen, P. E., Behnke, K., Oehrberg, S., Christiansen, P. E., Behnke, K., et al et al (1995) (1995) Paroxetine in the treatment of panic disorder.
Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. A randomised, double-blind, placebo-controlled study. Combined psychotherapy plus antidepressant therapy is more effective than either therapy alone for the acute-phase treatment of panic disorder with or without either therapy alone for the acute-phase treatment of panic disorder with or without agoraphobia (number needed to treat 7^10). Combined therapy produces more agoraphobia (number needed to treat 7^10). Combined therapy produces more drop-outs due to side-effects than psychotherapy alone (number needed to harm drop-outs due to side-effects than psychotherapy alone (number needed to harm around 26). around 26).
& & Combined therapy is as effective as psychotherapy and more effective than Combined therapy is as effective as psychotherapy and more effective than antidepressant pharmacotherapy after discontinuation of the acute-phase treatment antidepressant pharmacotherapy after discontinuation of the acute-phase treatment (number needed to treat around 6).
(number needed to treat around 6).
& & The evidence was most consistent for behavioural therapy and cognitiveThe evidence was most consistent for behavioural therapy and cognitiveb ehavioural therapy. behavioural therapy.
LIMITATIONS LIMITATIONS
& & The comparability of the treatment arms after termination of the acute-phase and
The comparability of the treatment arms after termination of the acute-phase and continuation treatments may be compromised by the naturalistic nature and continuation treatments may be compromised by the naturalistic nature and inadequate reporting of the follow-up. inadequate reporting of the follow-up. 
